Dear Doctor Roach: I read your recent column on COVID shots. Why do you still recommend these terribly dangerous vaccines and the boosters, in light of the overwhelming evidence that they’re causing ...

Researchers have been chasing the dream of a cancer vaccine for decades. Some recent successes with mRNA technology are garnering excitement from patients, doctors, government and investors.

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according ...

A new review synthesizes evidence that gut microbiota composition and metabolites such as short-chain fatty acids modulate ...

Cancer medicine had an extraordinary weekend in Madrid. At the European Society for Medical Oncology Congress, Amgen’s ...

Phase 3 trial results presented at ESMO 2026 show that adding personalized mRNA vaccine intismeran to pembrolizumab reduces ...

Adding a personalized mRNA-based cancer vaccine to immunotherapy after surgery for high-risk melanoma reduced the risk of recurrence or death by 42%, according to results from the phase 3 ...

The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.

Until now, the flu shot lineup featured six vaccination options —using live viruses, inactivated viruses or viral antigens—delivered via needle injection or nasal spray. The mRNA vaccine has proven ...

Drugs targeting the protein Wee1 looked promising, but an incomplete understanding of their mechanism likely led to the ...

Moderna and Merck’s personalized mRNA vaccine for melanoma reduced the risk of cancer recurrence and death by 42% compared ...